药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Pivampicillin
Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated)
The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Prednisolone phosphate.
Pivampicillin
Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated)
The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Prednisolone phosphate.
Pivampicillin
Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)
The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Prednisolone phosphate.
Pivampicillin
Clostridium tetani toxoid antigen (formaldehyde inactivated)
The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Prednisolone phosphate.
Pivampicillin
Bacillus calmette-guerin substrain tice live antigen
The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Prednisolone phosphate.
Pivampicillin
Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen
The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Prednisolone phosphate.
Pivampicillin
Varicella Zoster Vaccine (Live/attenuated)
The therapeutic efficacy of Varicella Zoster Vaccine (Live/attenuated) can be decreased when used in combination with Prednisolone phosphate.
Pivampicillin
Rubella virus vaccine
The therapeutic efficacy of Rubella virus vaccine can be decreased when used in combination with Prednisolone phosphate.
Pivampicillin
Rabies virus inactivated antigen, A
The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Prednisolone phosphate.
Pivampicillin
Rotavirus vaccine
The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Prednisolone phosphate.
Pivampicillin
Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen
The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Prednisolone phosphate.
Pivampicillin
Rabies virus inactivated antigen, B
The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Prednisolone phosphate.
Pivampicillin
Anthrax immune globulin human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Prednisolone phosphate.
Pivampicillin
TG4010
The therapeutic efficacy of TG4010 can be decreased when used in combination with Prednisolone phosphate.
Pivampicillin
Vitespen
The therapeutic efficacy of Vitespen can be decreased when used in combination with Prednisolone phosphate.
Pivampicillin
GI-5005
The therapeutic efficacy of GI-5005 can be decreased when used in combination with Prednisolone phosphate.
Pivampicillin
SRP 299
The therapeutic efficacy of SRP 299 can be decreased when used in combination with Prednisolone phosphate.
Pivampicillin
Rindopepimut
The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Prednisolone phosphate.
Pivampicillin
INGN 225
The therapeutic efficacy of INGN 225 can be decreased when used in combination with Prednisolone phosphate.
Pivampicillin
PEV3A
The therapeutic efficacy of PEV3A can be decreased when used in combination with Prednisolone phosphate.